カテゴリー： QYResearch, 世界

世界のT細胞免疫療法市場 2019年

【英語タイトル】Global T-Cell Immunotherapy Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X16291）・商品コード：DATA909X16291
・発行会社（調査会社）：QYResearch
・発行日：2019年11月22日（※2024年版があります。お問い合わせください）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、T細胞免疫療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CAR-T、TCR、TIL療法に、用途別には、胃がん、肺がん、大腸がん、食道がん、膵臓がん、その他にセグメント区分し、T細胞免疫療法の世界市場を分析しました。


・エグゼクティブ・サマリー
・T細胞免疫療法の世界市場概要
・T細胞免疫療法の製造コスト構成分析
・T細胞免疫療法の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・T細胞免疫療法の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・T細胞免疫療法のセグメント分析（種類別）
（CAR-T、TCR、TIL療法）
・T細胞免疫療法のセグメント分析（用途別）
（胃がん、肺がん、大腸がん、食道がん、膵臓がん、その他）
・T細胞免疫療法の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Adaptimmune、Altor Bioscience Corporation、Cellectis、Juno Therapeutics、Kite Pharma、Novartis、Takara Bio、Unum Therapeutics、）
・T細胞免疫療法の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global T-Cell Immunotherapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on T-Cell Immunotherapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall T-Cell Immunotherapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of T-Cell Immunotherapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their T-Cell Immunotherapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
CAR-T
TCR
TIL Therapies

Segment by Application
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of T-Cell Immunotherapy
1.1 Definition of T-Cell Immunotherapy
1.2 T-Cell Immunotherapy Segment by Type
1.2.1 Global T-Cell Immunotherapy Production Growth Rate Comparison by Types (2014-2025)
1.2.2 CAR-T
1.2.3 TCR
1.2.4 TIL Therapies
1.3 T-Cell Immunotherapy Segment by Applications
1.3.1 Global T-Cell Immunotherapy Consumption Comparison by Applications (2014-2025)
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophagus Cancer
1.3.6 Pancreatic Cancer
1.3.7 Others
1.4 Global T-Cell Immunotherapy Overall Market
1.4.1 Global T-Cell Immunotherapy Revenue (2014-2025)
1.4.2 Global T-Cell Immunotherapy Production (2014-2025)
1.4.3 North America T-Cell Immunotherapy Status and Prospect (2014-2025)
1.4.4 Europe T-Cell Immunotherapy Status and Prospect (2014-2025)
1.4.5 China T-Cell Immunotherapy Status and Prospect (2014-2025)
1.4.6 Japan T-Cell Immunotherapy Status and Prospect (2014-2025)
1.4.7 Southeast Asia T-Cell Immunotherapy Status and Prospect (2014-2025)
1.4.8 India T-Cell Immunotherapy Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of T-Cell Immunotherapy
2.3 Manufacturing Process Analysis of T-Cell Immunotherapy
2.4 Industry Chain Structure of T-Cell Immunotherapy

3 Development and Manufacturing Plants Analysis of T-Cell Immunotherapy
3.1 Capacity and Commercial Production Date
3.2 Global T-Cell Immunotherapy Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of T-Cell Immunotherapy
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 T-Cell Immunotherapy Production and Capacity Analysis
4.2 T-Cell Immunotherapy Revenue Analysis
4.3 T-Cell Immunotherapy Price Analysis
4.4 Market Concentration Degree

5 T-Cell Immunotherapy Regional Market Analysis
5.1 T-Cell Immunotherapy Production by Regions
5.1.1 Global T-Cell Immunotherapy Production by Regions
5.1.2 Global T-Cell Immunotherapy Revenue by Regions
5.2 T-Cell Immunotherapy Consumption by Regions
5.3 North America T-Cell Immunotherapy Market Analysis
5.3.1 North America T-Cell Immunotherapy Production
5.3.2 North America T-Cell Immunotherapy Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America T-Cell Immunotherapy Import and Export
5.4 Europe T-Cell Immunotherapy Market Analysis
5.4.1 Europe T-Cell Immunotherapy Production
5.4.2 Europe T-Cell Immunotherapy Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe T-Cell Immunotherapy Import and Export
5.5 China T-Cell Immunotherapy Market Analysis
5.5.1 China T-Cell Immunotherapy Production
5.5.2 China T-Cell Immunotherapy Revenue
5.5.3 Key Manufacturers in China
5.5.4 China T-Cell Immunotherapy Import and Export
5.6 Japan T-Cell Immunotherapy Market Analysis
5.6.1 Japan T-Cell Immunotherapy Production
5.6.2 Japan T-Cell Immunotherapy Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan T-Cell Immunotherapy Import and Export
5.7 Southeast Asia T-Cell Immunotherapy Market Analysis
5.7.1 Southeast Asia T-Cell Immunotherapy Production
5.7.2 Southeast Asia T-Cell Immunotherapy Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia T-Cell Immunotherapy Import and Export
5.8 India T-Cell Immunotherapy Market Analysis
5.8.1 India T-Cell Immunotherapy Production
5.8.2 India T-Cell Immunotherapy Revenue
5.8.3 Key Manufacturers in India
5.8.4 India T-Cell Immunotherapy Import and Export

6 T-Cell Immunotherapy Segment Market Analysis (by Type)
6.1 Global T-Cell Immunotherapy Production by Type
6.2 Global T-Cell Immunotherapy Revenue by Type
6.3 T-Cell Immunotherapy Price by Type

7 T-Cell Immunotherapy Segment Market Analysis (by Application)
7.1 Global T-Cell Immunotherapy Consumption by Application
7.2 Global T-Cell Immunotherapy Consumption Market Share by Application (2014-2019)

8 T-Cell Immunotherapy Major Manufacturers Analysis
8.1 Adaptimmune
8.1.1 Adaptimmune T-Cell Immunotherapy Production Sites and Area Served
8.1.2 Adaptimmune Product Introduction, Application and Specification
8.1.3 Adaptimmune T-Cell Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Altor Bioscience Corporation
8.2.1 Altor Bioscience Corporation T-Cell Immunotherapy Production Sites and Area Served
8.2.2 Altor Bioscience Corporation Product Introduction, Application and Specification
8.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Cellectis
8.3.1 Cellectis T-Cell Immunotherapy Production Sites and Area Served
8.3.2 Cellectis Product Introduction, Application and Specification
8.3.3 Cellectis T-Cell Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Juno Therapeutics
8.4.1 Juno Therapeutics T-Cell Immunotherapy Production Sites and Area Served
8.4.2 Juno Therapeutics Product Introduction, Application and Specification
8.4.3 Juno Therapeutics T-Cell Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Kite Pharma
8.5.1 Kite Pharma T-Cell Immunotherapy Production Sites and Area Served
8.5.2 Kite Pharma Product Introduction, Application and Specification
8.5.3 Kite Pharma T-Cell Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novartis
8.6.1 Novartis T-Cell Immunotherapy Production Sites and Area Served
8.6.2 Novartis Product Introduction, Application and Specification
8.6.3 Novartis T-Cell Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Takara Bio
8.7.1 Takara Bio T-Cell Immunotherapy Production Sites and Area Served
8.7.2 Takara Bio Product Introduction, Application and Specification
8.7.3 Takara Bio T-Cell Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Unum Therapeutics
8.8.1 Unum Therapeutics T-Cell Immunotherapy Production Sites and Area Served
8.8.2 Unum Therapeutics Product Introduction, Application and Specification
8.8.3 Unum Therapeutics T-Cell Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of T-Cell Immunotherapy Market
9.1 Global T-Cell Immunotherapy Market Trend Analysis
9.1.1 Global T-Cell Immunotherapy Market Size (Volume and Value) Forecast 2019-2025
9.2 T-Cell Immunotherapy Regional Market Trend
9.2.1 North America T-Cell Immunotherapy Forecast 2019-2025
9.2.2 Europe T-Cell Immunotherapy Forecast 2019-2025
9.2.3 China T-Cell Immunotherapy Forecast 2019-2025
9.2.4 Japan T-Cell Immunotherapy Forecast 2019-2025
9.2.5 Southeast Asia T-Cell Immunotherapy Forecast 2019-2025
9.2.6 India T-Cell Immunotherapy Forecast 2019-2025
9.3 T-Cell Immunotherapy Market Trend (Product Type)
9.4 T-Cell Immunotherapy Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 T-Cell Immunotherapy Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of T-Cell Immunotherapy
Table Global T-Cell Immunotherapy Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global T-Cell Immunotherapy Production Market Share by Types in 2018
Figure CAR-T Product Picture
Figure TCR Product Picture
Figure TIL Therapies Product Picture
Table Global T-Cell Immunotherapy Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global T-Cell Immunotherapy Consumption Market Share by Applications in 2018
Figure Stomach Cancer
Figure Lung Cancer
Figure Colorectal Cancer
Figure Esophagus Cancer
Figure Pancreatic Cancer
Figure Others
Figure Global T-Cell Immunotherapy Revenue (Million USD) (2014-2025)
Figure Global T-Cell Immunotherapy Production (K Units) (2014-2025)
Figure North America T-Cell Immunotherapy Market Size (Million USD) (2014-2025)
Figure Europe T-Cell Immunotherapy Market Size (Million USD) (2014-2025)
Figure China T-Cell Immunotherapy Market Size (Million USD) (2014-2025)
Figure Japan T-Cell Immunotherapy Market Size (Million USD) (2014-2025)
Figure Southeast Asia T-Cell Immunotherapy Market Size (Million USD) (2014-2025)
Figure India T-Cell Immunotherapy Market Size (Million USD) (2014-2025)
Table T-Cell Immunotherapy Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of T-Cell Immunotherapy in 2018
Figure Manufacturing Process Analysis of T-Cell Immunotherapy
Figure Industry Chain Structure of T-Cell Immunotherapy
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global T-Cell Immunotherapy Manufacturing Plants Distribution
Table T-Cell Immunotherapy Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table T-Cell Immunotherapy Capacity (K Units) of Major Manufacturers (2014-2019)
Table T-Cell Immunotherapy Production (K Units) of Major Manufacturers (2014-2019)
Table T-Cell Immunotherapy Production Market Share of Major Manufacturers (2014-2019)
Figure T-Cell Immunotherapy Production Share by Manufacturers in 2018
Table T-Cell Immunotherapy Revenue (Million US$) of Major Manufacturers (2014-2019)
Table T-Cell Immunotherapy Revenue Market Share of Major Manufacturers (2014-2019)
Figure T-Cell Immunotherapy Revenue Share by Manufacturers in 2018
Table T-Cell Immunotherapy Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global T-Cell Immunotherapy Production by Regions 2014-2019 (K Units)
Table Global T-Cell Immunotherapy Production Market Share by Regions 2014-2019
Figure Global T-Cell Immunotherapy Production Market Share by Regions in 2018
Table Global T-Cell Immunotherapy Revenue by Regions 2014-2019 (Million USD)
Table Global T-Cell Immunotherapy Revenue Market Share by Regions 2014-2019
Figure Global T-Cell Immunotherapy Revenue Market Share by Regions in 2018
Table Global T-Cell Immunotherapy Consumption by Regions 2014-2019 (K Units)
Table Global T-Cell Immunotherapy Consumption Market Share by Regions 2014-2019
Figure North America T-Cell Immunotherapy Production Growth Rate 2014-2019 (K Units)
Figure North America T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million USD)
Table North America T-Cell Immunotherapy Production, Consumption Import and Export (K Units)
Figure Europe T-Cell Immunotherapy Production Growth Rate 2014-2019 (K Units)
Figure Europe T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million USD)
Table Europe T-Cell Immunotherapy Production, Consumption Import and Export (K Units)
Figure China T-Cell Immunotherapy Production Growth Rate 2014-2019 (K Units)
Figure China T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million USD)
Table China T-Cell Immunotherapy Production, Consumption Import and Export (K Units)
Figure Japan T-Cell Immunotherapy Production Growth Rate 2014-2019 (K Units)
Figure Japan T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million USD)
Table Japan T-Cell Immunotherapy Production, Consumption Import and Export (K Units)
Figure Southeast Asia T-Cell Immunotherapy Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia T-Cell Immunotherapy Production, Consumption Import and Export (K Units)
Figure India T-Cell Immunotherapy Production Growth Rate 2014-2019 (K Units)
Figure India T-Cell Immunotherapy Revenue Growth Rate 2014-2019 (Million USD)
Table India T-Cell Immunotherapy Production, Consumption Import and Export (K Units)
Figure Global Consumption T-Cell Immunotherapy Market Share by Application (2014-2019)
Figure Global Value (Consumption) T-Cell Immunotherapy Market Share by Application (2014-2019)
Table Adaptimmune T-Cell Immunotherapy Production Sites and Area Served
Table Adaptimmune T-Cell Immunotherapy Product Introduction, Application and Specification
Table Adaptimmune T-Cell Immunotherapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Adaptimmune T-Cell Immunotherapy Production Growth Rate (2014-2019)
Table Adaptimmune T-Cell Immunotherapy Production Market Share (2014-2019)
Figure Adaptimmune T-Cell Immunotherapy Revenue Market Share (2014-2019)
Table Adaptimmune T-Cell Immunotherapy Main Business and Markets Served
Table Altor Bioscience Corporation T-Cell Immunotherapy Production Sites and Area Served
Table Altor Bioscience Corporation T-Cell Immunotherapy Product Introduction, Application and Specification
Table Altor Bioscience Corporation T-Cell Immunotherapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Altor Bioscience Corporation T-Cell Immunotherapy Production Growth Rate (2014-2019)
Table Altor Bioscience Corporation T-Cell Immunotherapy Production Market Share (2014-2019)
Figure Altor Bioscience Corporation T-Cell Immunotherapy Revenue Market Share (2014-2019)
Table Altor Bioscience Corporation T-Cell Immunotherapy Main Business and Markets Served
Table Cellectis T-Cell Immunotherapy Production Sites and Area Served
Table Cellectis T-Cell Immunotherapy Product Introduction, Application and Specification
Table Cellectis T-Cell Immunotherapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cellectis T-Cell Immunotherapy Production Growth Rate (2014-2019)
Table Cellectis T-Cell Immunotherapy Production Market Share (2014-2019)
Figure Cellectis T-Cell Immunotherapy Revenue Market Share (2014-2019)
Table Cellectis T-Cell Immunotherapy Main Business and Markets Served
Table Juno Therapeutics T-Cell Immunotherapy Production Sites and Area Served
Table Juno Therapeutics T-Cell Immunotherapy Product Introduction, Application and Specification
Table Juno Therapeutics T-Cell Immunotherapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Juno Therapeutics T-Cell Immunotherapy Production Growth Rate (2014-2019)
Table Juno Therapeutics T-Cell Immunotherapy Production Market Share (2014-2019)
Figure Juno Therapeutics T-Cell Immunotherapy Revenue Market Share (2014-2019)
Table Juno Therapeutics T-Cell Immunotherapy Main Business and Markets Served
Table Kite Pharma T-Cell Immunotherapy Production Sites and Area Served
Table Kite Pharma T-Cell Immunotherapy Product Introduction, Application and Specification
Table Kite Pharma T-Cell Immunotherapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Kite Pharma T-Cell Immunotherapy Production Growth Rate (2014-2019)
Table Kite Pharma T-Cell Immunotherapy Production Market Share (2014-2019)
Figure Kite Pharma T-Cell Immunotherapy Revenue Market Share (2014-2019)
Table Kite Pharma T-Cell Immunotherapy Main Business and Markets Served
Table Novartis T-Cell Immunotherapy Production Sites and Area Served
Table Novartis T-Cell Immunotherapy Product Introduction, Application and Specification
Table Novartis T-Cell Immunotherapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis T-Cell Immunotherapy Production Growth Rate (2014-2019)
Table Novartis T-Cell Immunotherapy Production Market Share (2014-2019)
Figure Novartis T-Cell Immunotherapy Revenue Market Share (2014-2019)
Table Novartis T-Cell Immunotherapy Main Business and Markets Served
Table Takara Bio T-Cell Immunotherapy Production Sites and Area Served
Table Takara Bio T-Cell Immunotherapy Product Introduction, Application and Specification
Table Takara Bio T-Cell Immunotherapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Takara Bio T-Cell Immunotherapy Production Growth Rate (2014-2019)
Table Takara Bio T-Cell Immunotherapy Production Market Share (2014-2019)
Figure Takara Bio T-Cell Immunotherapy Revenue Market Share (2014-2019)
Table Takara Bio T-Cell Immunotherapy Main Business and Markets Served
Table Unum Therapeutics T-Cell Immunotherapy Production Sites and Area Served
Table Unum Therapeutics T-Cell Immunotherapy Product Introduction, Application and Specification
Table Unum Therapeutics T-Cell Immunotherapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Unum Therapeutics T-Cell Immunotherapy Production Growth Rate (2014-2019)
Table Unum Therapeutics T-Cell Immunotherapy Production Market Share (2014-2019)
Figure Unum Therapeutics T-Cell Immunotherapy Revenue Market Share (2014-2019)
Table Unum Therapeutics T-Cell Immunotherapy Main Business and Markets Served
Figure Global T-Cell Immunotherapy Production (K Units) Growth Rate Forecast 2019-2025
Figure Global T-Cell Immunotherapy Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global T-Cell Immunotherapy Sales Price (USD/Unit) Forecast 2019-2025
Figure North America T-Cell Immunotherapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America T-Cell Immunotherapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe T-Cell Immunotherapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe T-Cell Immunotherapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China T-Cell Immunotherapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure China T-Cell Immunotherapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan T-Cell Immunotherapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan T-Cell Immunotherapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia T-Cell Immunotherapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia T-Cell Immunotherapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India T-Cell Immunotherapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure India T-Cell Immunotherapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of T-Cell Immunotherapy by Type (2019-2025)
Table Global Consumption (K Units) of T-Cell Immunotherapy by Application (2019-2025)
Table T-Cell Immunotherapy Distributors List
Table T-Cell Immunotherapy Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Adaptimmune、Altor Bioscience Corporation、Cellectis、Juno Therapeutics、Kite Pharma、Novartis、Takara Bio、Unum Therapeutics、

★調査レポート[世界のT細胞免疫療法市場 2019年] (コード：DATA909X16291)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のT細胞免疫療法市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • マントル細胞リンパ腫治療法の世界市場：規模・現状・予測2019-2025
    DATA909X18670 / QYResearch / 2019年11月25日 / ※当調査レポートでは、マントル細胞リンパ腫治療法の世界市場について調査・分析し、マントル細胞リンパ腫治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（病院、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のマントル細胞リンパ腫治療法市場動向 ・主要企業別マーケットシェア ・マントル細胞リンパ腫治療法の種類別市場規模2014-2019 （併用療法、単剤療法） ・マントル細胞リンパ腫治療法の用途別市場規模2014-2019 （病院、研究所、その他） ・マントル細胞リンパ腫治療法の北米市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.Nonetheless, progress in the clinical use of mAbs is hindered by poor efficacy, off-target toxicities and drug resistance. Thus, novel mAbs engineering and approaches to improve target specificity and enhance affinity and potency are required. In 2018, the global Mantle Cell Lymphoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of...

    • ◆H&Iグローバルリサーチのお客様（例）◆